Cristina Masuet-Aumatell

Dr. Cristina Masuet-Aumatell

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Journal of Mental Health
Verified
Journal Article
Open access
PDF file
Fernando Fernández-ArandaFernando Fernández-Aranda
Fernando Fernández-Aranda
Susana Jiménez-MurciaSusana Jiménez-Murcia
Susana Jiménez-Murcia
JSJuan José Santamaría
Juan José Santamaría
KGKatarina Gunnard
Katarina Gunnard
ASAntonio Soto
Antonio Soto
EPEva Penelo
Eva Penelo
Previous review studies have suggested that computer games can serve as an alternative or additional form of treatment in several areas (schizophrenia, asthma or motor rehabilitation). Although several naturalistic studies have been conducted showing the usefulness of serious video games in the treatment of some abnormal behaviours, there is a lack of serious games specially designed for treating mental disorders. The purpose of our project was to develop and evaluate a serious video game designed to remediate attitudinal, behavioural and emotional processes of patients with impulse-related disorders. The video game was created and developed within the European research project PlayMancer. It aims to prove potential capacity to change underlying attitudinal, behavioural and emotional processes of patients with impulse-related disorders. New interaction modes were provided by newly developed components, such as emotion recognition from speech, face and physiological reactions, while specific impulsive reactions were elicited. The video game uses biofeedback for helping patients to learn relaxation skills, acquire better self-control strategies and develop new emotional regulation strategies. In this article, we present a description of the video game used, rationale, user requirements, usability and preliminary data, in several mental disorders.

31 August 2006 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
PTPilar Teixidor
Pilar Teixidor
PGPeggy Gatignol
Peggy Gatignol
MLMarianne Leroy
Marianne Leroy
CMCristina Masuet-Aumatell
Cristina Masuet-Aumatell
LCLaurent Capelle
Laurent Capelle
HDHugues Duffau
Hugues Duffau

6 February 2006 in Critical Care
Verified
Journal Article
Open access
PDF file
SHStephan Harbarth
Stephan Harbarth
CMCristina Masuet-Aumatell
Cristina Masuet-Aumatell
JSJacques Schrenzel
Jacques Schrenzel
PFPatrice François
Patrice François
CAChristophe Akakpo
Christophe Akakpo
Didier PittetDidier Pittet
Didier Pittet
Introduction: Rapid diagnostic tests may allow early identification of previously unknown methicillin-resistant Staphylococcus aureus (MRSA) carriers at intensive care unit (ICU) admission. The aim of this study was twofold: first, to assess whether a new molecular MRSA screening test can substantially decrease the time between ICU admission and identification of MRSA carriers; and, second, to examine the combined effect of rapid testing and pre-emptive contact isolation on MRSA infections. Method: Since November 2003, patients admitted for longer than 24 hours to two adult ICUs were screened systematically on admission using quick, multiplex immunocapture-coupled PCR (qMRSA). Median time intervals from admission to notification of test results were calculated for a five-month intervention phase (November 2003–March 2004) and compared with a historical control period (April 2003–October 2003) by nonparametric tests. ICU-acquired MRSA infection rates were determined for an extended surveillance period (January 2003 through August 2005) and analyzed by Poisson regression methods. Results: During the intervention phase, 97% (450/462) of patients admitted to the surgical ICU and 80% (470/591) of patients admitted to the medical ICU were screened. On-admission screening identified the prevalence of MRSA to be 6.7% (71/1053). Without admission screening, 55 previously unknown MRSA carriers would have been missed in both ICUs. Median time from ICU admission to notification of test results decreased from 87 to 21 hours in the surgical ICU (P < 0.001) and from 106 to 23 hours in the medical ICU (P < 0.001). In the surgical ICU, 1,227 pre-emptive isolation days for 245 MRSA-negative patients were saved by using the qMRSA test. After adjusting for colonization pressure, the systematic on-admission screening and pre-emptive isolation policy was associated with a reduction in medical ICU acquired MRSA infections (relative risk 0.3, 95% confidence interval 0.1–0.7) but had no effect in the surgical ICU (relative risk 1.0, 95% confidence interval 0.6–1.7). Conclusion: The qMRSA test decreased median time to notification from four days to one day and helped to identify previously unknown MRSA carriers rapidly. A strategy linking the rapid screening test to pre-emptive isolation and cohorting of MRSA patients substantially reduced MRSA cross-infections in the medical but not in the surgical ICU.

1 March 2021 in Travel Medicine and Infectious Disease
Verified
Journal Article
Open access
CMCristina Masuet-Aumatell
Cristina Masuet-Aumatell
JAJorge Atouguia
Jorge Atouguia
Typhoid fever is a bacterial infection caused by the Gram-negative bacterium Salmonella enterica subspecies enterica serovar Typhi (S. Typhi), prevalent in many low- and middle-income countries. In high-income territories, typhoid fever is predominantly travel-related, consequent to travel in typhoid-endemic regions; however, data show that the level of typhoid vaccination in travellers is low. Successful management of typhoid fever using antibiotics is becoming increasingly difficult due to drug resistance; emerging resistance has spread geographically due to factors such as increasing travel connectivity, affecting those in endemic regions and travellers alike. This review provides an overview of: the epidemiology and diagnosis of typhoid fever; the emergence of drug-resistant typhoid strains in the endemic setting; drug resistance observed in travellers; vaccines currently available to prevent typhoid fever; vaccine recommendations for people living in typhoid-endemic regions; strategies for the introduction of typhoid vaccines and stakeholders in vaccination programmes; and travel recommendations for a selection of destinations with a medium or high incidence of typhoid fever.

15 January 2009 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
Isabel KrugIsabel Krug
Isabel Krug
APAndrea Poyastro Pinheiro
Andrea Poyastro Pinheiro
CBCynthia Bulik
Cynthia Bulik
Susana Jiménez-MurciaSusana Jiménez-Murcia
Susana Jiménez-Murcia
Roser GraneroRoser Granero
Roser Granero
Fernando Fernández-ArandaFernando Fernández-Aranda
Fernando Fernández-Aranda

5 April 2007 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
JAJ. J. Acebes
J. J. Acebes
JMJ. Martino
J. Martino
CMCristina Masuet-Aumatell
Cristina Masuet-Aumatell
EMEduard Montanya
Eduard Montanya
JSJ. Soler
J. Soler